title: Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.
abstract: Inhibition or blockade of myostatin, a negative growth factor of skeletal muscle, enhances muscle growth and therefore is considered a promising strategy for the treatment of muscle-wasting diseases such as the muscular dystrophies. Previously, we showed that myostatin blockade in both normal and dystrophin-deficient mdx mice by systemic delivery of the myostatin propeptide (MPRO) gene by an adeno-associated virus serotype 8 (AAV8) vector could enhance muscle growth and ameliorate dystrophic lesions. Here, we further investigate whether the muscle growth effect of myostatin blockade can be achieved in dogs by gene transfer. First, we cloned the canine MPRO gene, packaged it in the AAV8 vector, and showed robust muscle-enhancing effects after systemic delivery into neonatal mice. This vector was then further tested in two 3-month-old normal dogs (weighing 9.7 and 6.3 kg). The vector was delivered to one limb by hydrodynamic vein injection, and the contralateral limb served as a control. The delivery procedure was safe, without discernible adverse effects. AAV vector DNA and MPRO gene expression were detected by quantitative polymerase chain reaction, Western blotting, and immunofluorescence staining of muscle biopsies. Overexpression of MPRO resulted in enhanced muscle growth without a cytotoxic T lymphocytic immune response, as evidenced by larger myofibers in multiple muscles, increased muscle volume determined by magnetic resonance imaging, and the lack of CD4+ and CD8+ T cell infiltration in the vector-injected limbs. Our preliminary study thus supports further investigation of this therapeutic strategy in the dystrophin-deficient golden retriever muscular dystrophy dog model.
authors.affiliation: Division of Molecular Pharmaceutics, University of North Carolina School of Pharmacy, Chapel Hill, NC 27599, USA.
authors.forename: Chunping
authors.initials: C
authors.lastname: Qiao
authors.forename: Juan
authors.initials: J
authors.lastname: Li
authors.forename: Hui
authors.initials: H
authors.lastname: Zheng
authors.forename: Janet
authors.initials: J
authors.lastname: Bogan
authors.forename: Jianbin
authors.initials: J
authors.lastname: Li
authors.forename: Zhenhua
authors.initials: Z
authors.lastname: Yuan
authors.forename: Cheng
authors.initials: C
authors.lastname: Zhang
authors.forename: Dan
authors.initials: D
authors.lastname: Bogan
authors.forename: Joe
authors.initials: J
authors.lastname: Kornegay
authors.forename: Xiao
authors.initials: X
authors.lastname: Xiao
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D004285:Dogs; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D007275:Injections, Intravenous / Q000379:methods; D008297:Male; D051379:Mice; D024510:Muscle Development / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D055435:Myostatin / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D010455:Peptides / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D012703:Serotyping
chemical_list: D055435:Myostatin; D010455:Peptides